Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GenovaTSE:9341 +0.33%77 Days Inventory is 4.34 as of Mar. 2026, which is 24% below its 10-year median of 5.72. GuruFocus rates TSE:9341 with a GF Score™ of 77/100 and a GF Value™ of 円1,963.44 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Genova ranks better than 99.36% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Genova's Average Total Inventories for the
six
months ended in Mar. 2026 was 円73 Mil. Genova's Cost of Goods Sold for the
six
months ended in Mar. 2026 was 円3,085 Mil.
Hence, Genova's Days Inventory for the
six
months ended in Mar. 2026 was 4.34.
The historical rank and industry rank for Genova's Days Inventory or its related term are showing as below:
TSE:9341'
s Days Inventory Range Over the Past 10 Years
Min: 4.71 Med: 5.72 Max: 9.77
Current: 4.71
During the past 6 years, Genova's highest Days Inventory was 9.77. The lowest was 4.71. And the median was 5.72.
TSE:9341's Days Inventory is ranked better than 99.36% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.47
vs TSE:9341: 4.71
Genova's Days Inventory
declined
from Mar. 2025 (7.91) to Mar. 2026 (4.34).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Genova's Inventory Turnover for the
six
months ended in Mar. 2026 was 42.01.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Genova's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.01.
Genova (TSE:9341) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Genova's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Genova's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Genova Days Inventory Related Terms
Genova Days Inventory Historical Data
* Premium members only.
The historical data trend for Genova's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9341 vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Genova's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genova Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Genova's Days Inventory distribution charts can be found below:
* The bar in red indicates where Genova's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genova (TSE:9341) has a Days Inventory of 4.34 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Genova and its competitors. This is 24% below median its historical median of 5.72. Over the past decade, Genova's Days Inventory has ranged from 4.71 to 9.77. According to the industry distribution chart, Genova ranks #5 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 0.59999999999999%.
Is Genova's Days Inventory too high?
Genova's current Days Inventory of 4.34 is 24% below median its 10-year median of 5.72. Over the past 10 years, this metric has ranged from a low of 4.71 to a high of 9.77. The Medical Devices & Instruments industry median Days Inventory is 179.47. Genova's value of 4.34 is 97.6% below this industry median. Based on the distribution chart, Genova ranks #5 out of 787 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Genova has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Genova's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Genova ranks #5 out of 787 companies for Days Inventory. This places Genova in the top 1% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.47. Genova's value of 4.34 is 97.6% below this benchmark. Historically, Genova's own Days Inventory has ranged from 4.71 to 9.77 over the past decade. While the company's 10-year median is 5.72 vs. the industry median of 179.47, Genova has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.47, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genova's current Days Inventory of 4.34 is 97.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Genova and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genova's current Days Inventory is 4.34, which is 24% below median its own 10-year median of 5.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genova stock overvalued right now?
Based on GuruFocus' analysis, Genova (TSE:9341) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,963.44, compared to a current price of 円613.00 — trading 68.8% below its estimated fair value. The current Days Inventory is 4.34, which is 24% below median its 10-year median of 5.72 and 97.6% below the Medical Devices & Instruments industry median of 179.47. Genova's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Genova (TSE:9341), the current Days Inventory is 4.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genova (TSE:9341) Overvalued in 2026?
Based on GuruFocus' analysis, Genova stock appears to be undervalued.
The current stock price of 円613.00 is trading 68.8% below its estimated GF Value™ of 円1,963.44.
GuruFocus considers Genova to be Possible Value Trap.
Key valuation signals for TSE:9341:
Days Inventory: 4.34 (24% below median its 10-year median of 5.72)
GF Value™: 円1,963.44 vs. price of 円613.00 (68.8% below fair value)
Industry Position: 97.6% below the Medical Devices & Instruments median (#5 of 787)
No single metric tells the full story. See the TSE:9341 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genova Inc manages operations of the medical information site and sales of automatic reception and payment machines for clinics. The group operates in two reportable segments: Medical Platform Business and the Smart Clinic Project. The majority of its revenue is generated from the Medical Platform Business, which operates an online media site (Medical Dock) that provides preventive information and health knowledge to users (patients) on diseases and symptoms. In addition, it also supports users in finding a family doctor that suits them. The Smart Clinic Business develops and provides services that improve the convenience and efficiency of non-medical procedures at medical institutions.
77GF Score
Get the complete analysis for TSE:9341
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9341 has been successfully added to your 
